New Researches In Treatment Of Rheumatoid Arthritis

New Researches In Treatment Of Rheumatoid Arthritis.

About half of rheumatoid arthritis patients stopped taking their medications within two years after they started them, a altered con finds June 2013. Rheumatoid arthritis affects about one in 100 mobile vulgus worldwide and can cause reformist joint destruction, deformity, pain and stiffness. The disease can reduce earthly function, quality of life and life expectancy. The main reason about one-third of patients discontinued their medications was because the drugs confused their effectiveness, the study authors found find out more. Other reasons included aegis concerns (20 percent), doctor preference (nearly 28 percent), submissive preference (about 18 percent) and access to treatment (9 percent), according to the survey results, which were presented Thursday at the annual meeting of the European League Against Rheumatism (EULAR), in Madrid, Spain.

Rheumatoid arthritis "is a continuous disease, which, if left untreated, can significantly and unendingly reduce joint function, patient mobility and quality of life," study lead prime mover Dr Vibeke Strand, a clinical professor at Stanford University School of Medicine, said in an EULAR news programme release "Studies have shown that patients sustain maximum benefit from rheumatoid arthritis care in the first two years - yet our data highlight significant discontinuation rates during this hour period".

The study included more than 6200 rheumatoid arthritis patients who started treatment by taking either tumor necrosis intermediary inhibitors (TNFi) or non-TNFi biologics. In the TNFi group, the percentages of patients who continued taking their medications were about 82 percent at six months, 68 percent at 12 months and 52 percent at 24 months.

In the non-TNFi group, the percentages for those corresponding interval periods were about 81 percent, 63 percent and 46 percent, respectively. The mean lifetime to medication discontinuation was 26,5 months in the TNFi faction and 20,5 months in the non-TNFi group, the investigators found.

"While there is no dry for rheumatoid arthritis, initiating treatment early and improving adherence can expedite patients to lead active and productive lives," Strand said in the information release more information. The data and conclusions of research presented at medical meetings should be viewed as precedence until published in a peer-reviewed journal.

tag : percent arthritis rheumatoid patients months treatment group study medications

Post a comment

Private comment



Dr. Alejandra Falto

Новые записи
Новые комментарии
Новые трэкбэки
Архив по месяцам
Форма поиска
RSS ссылка
Формуляр приглашения в блог-друзья

Добавить автора в блог-друзья